| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |